Inflammatory bowel diseases (IBD) encompass two main entities including ulcerative colitis
and Crohn's disease. Although having a common global pathophysiological mechanism …

Alcohol is one of the most widely used substances. Alcohol use accounts for 5.1% of the
global disease burden, contributes substantially to societal and economic costs, and leads …

Substance use disorders (SUDs) are highly prevalent and exact a large toll on individuals'
health, well‐being, and social functioning. Long‐lasting changes in brain networks involved …

This pilot study investigated psilocybin-induced changes in neural reactivity to alcohol and
emotional cues in patients with alcohol use disorder (AUD). Participants were recruited from …

Microbiome alterations are emerging as one of the most important factors that influence the
course of alcohol use disorder (AUD). Recent advances in bioinformatics enable more …

Compounds known to be successful in the treatment of alcohol use disorder include the
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …

Abstract Alcohol Use Disorder (AUD) is a multifaceted relapsing disorder that is commonly
comorbid with psychiatric disorders, including anxiety. Alcohol exposure produces a …

Alcohol cue exposure is a widely used experimental paradigm for screening
pharmacotherapies for alcohol use disorder (AUD). Medication‐related reductions in cue …

Drug repurposing is the process of identifying a new use for an existing drug or active
substance in an indication outside the scope of the original indication. Drug repurposing has …

Background: Topiramate (TPM) has the potential to become one of the most prominent
treatment options for alcohol use disorder (AUD). We investigated the efficacy of TPM for …